CML, CML-CP,MMR,TKI
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Study of the Efficacy and the Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With CML (NCT02204644) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2014-06-01 |
Track CML, CML-CP,MMR,TKI automatically
Every clearance here is in the API, with alerts when new ones post.